- Home
- SSKN vs ADIL Comparison
SSKN vs ADIL Comparison
Compare SSKN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSKN | ADIL |
|---|---|---|
| Founded | 1989 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 7.8M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SSKN | ADIL |
|---|---|---|
| Price | $1.44 | $0.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $6.00 | $1.50 |
| AVG Volume (30 Days) | 83.8K | ★ 356.0K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $30,980,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.74 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.24 | $0.22 |
| 52 Week High | $3.86 | $1.30 |
Technical Indicators
Market Signals| Indicator | SSKN | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 43.30 |
| Support Level | $1.24 | $0.30 |
| Resistance Level | $1.53 | $0.33 |
| Average True Range (ATR) | 0.09 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 68.97 | 54.70 |
Price Performance
Historical ComparisonAbout SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.